Benefit, Ingredient & Evidence Trend Insights

The Work

The distance between consumer interest in a benefit, the scientific credibility of an ingredient, and the regulatory feasibility of the claim you'd actually want to make is often the difference between a successful launch and a quiet retirement. Consumer interest moves first. Science catches up unevenly. Regulatory frameworks accept some claims and decline others. Most brands underestimate how far apart those three timelines can sit.

The pattern is familiar: a benefit space goes loud in social and influencer channels, a brand decides to enter, the formulation gets built around the ingredients with the strongest consumer narrative, and only later does anyone test whether the claims are actually defensible — with the agency, with retailers, with a plaintiffs' bar that is increasingly active in this space. By then, the product has been engineered around claims that don't hold.

Timing is the other half of the problem. Entering a benefit area too early means consumer demand isn't yet large enough to support the investment. Entering too late means competitors have already secured the credible ingredient supply, the scientific narrative, and the share-of-voice. The window where the three timelines align is narrower than it looks.

RGM's benefit, ingredient, and evidence trend work brings all three together for a specific question: should you enter this space, with this ingredient, with these claims, on this timeline? The work is most active across supplements, women's health, longevity, gut health, skin health, and postbiotics — categories where consumer interest, scientific evolution, and regulatory feasibility are all moving at once.